common bile duct. Approximately 35 minutes after the start of surgery operative cholangiography was performed which revealed failure of passage of contrast medium into the duodenum, and a fusiform (bird's beak) appearance of the distal portion of the common bile duct. The cholangiographic appearances were compatible with spasm of the biliary sphincter and glucagon 0.3 mg was administered intravenously. Cholangiography was repeated after 2 minutes and this revealed unhindered passage of contrast medium into the duodenum.
DISCUSSION
The incidence of retained residual calculi is reported as being decreased from 19070 to 4070 with operative cholangiography. I It involves minimal or no operative morbidity, whereas the mortality following re-exploration of the common bile duct is twice that of the original operation. 2 It may be difficult to interpret films that fail to demonstrate contrast medium entering the duodenum. Obstruction to the flow of contrast medium may be due to a stone or tumour. It may also be due to spasm of the choledochoduodenal sphincter. This may be caused by surgical manipulation or instrumentation in the region of the distal common bile duct or initiated by narcotic analgesic drugs administered for preanaesthetic medication or intraoperatively. In the case presented there had been no exploration or instrumentation of the common bile duct. The patient had received no intraoperative narcotic supplements, but approximately two hours before cholangiography had received papaveretum 20 mg as premedication. It has Anaesthesia and Intensive Care, Vol. 11. No. 2. Alay, 1983 been reported that 10.5 mg of morphine significantly raises biliary pressure for over two hours.3 However, hyoscine was also administered with the papaveretum and might be expected to minimise any rise in biliary pressure. As Scholz has pointed out it is often difficult to be certain of the cause of biliary sphincter spasm. 4 Whatever the stimulus, sphincter spasm was promptly reversed with 0.3 mg of glucagon administered intravenously.
Relaxation of the sphincter to allow bile to pass into the duodenum in response to a fatcontaining meal is predominantly mediated by cholecystokinin. 5 There are afferent and efferent nerve endings from the vagus nerve in the region of the sphincter, but it is reported that neural mechanisms do not play a significant role in sphincter relaxation. 6 A number of pharmacological agents have been reported to reduce intrabiliary pressure by relaxing the choledochoduodenal sphincter. These include anticholinergic drugs and, for narcotic-induced spasm, narcotic antagonists such as naloxone. 7 Glucagon is replacing anticholinergic drugs in gastrointestinal radiology because it is more reliable in producing relaxation of smooth muscle and causes less side effects than anticholinergics. 8 In addition atropine is only partially effective in reversing narcotic-induced spasm. 9 Naloxone will reverse biliary sphincter spasm if narcoticinduced and at the expense of reversing analgesia -an important consideration in operative anaesthetic management. Glucagon has been reported previously to reverse narcotic-induced spasm to and, interestingly, has been used as an anti-spasmodic in the treatment of acute diverticulitis.ll In the former report, however, it was administered in a high dose (10 mg) and as Miller and his colleagues have demonstrated even a dose of 2 mg administered intravenously will cause nausea and vomiting in over one third of volunteers. 8 Sphincter relaxation with glucagon has been suggested to be mediated by a glucagon-induced increase in Anaesrhesia and Intensive Care, Vol. J I, No. 2, .tvto)" 1983 smooth muscle cell cyclic adenosine 3':5'monophosphate (cAMP). IO We therefore suggest that the administration of glucagon in low dose (0.3 mg) should be considered during operative cholangiography when spasm of the choledochoduodenal sphincter is thought to be the cause of failure of passage of contrast medium into the duodenum. Administration of this dose should minimise the risks of postoperative nausea and vomiting as well as reducing the incidence of other side effects, such as transient cardiovascular stimulation and hyperglycaemia.
